Group One Trading’s Antares Pharma, Inc. ATRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-13,427
| Closed | -$55K | – | 8908 |
|
|
2022
Q1 | $55K | Buy |
+13,427
| New | +$48.7K | ﹤0.01% | 6029 |
|
|
2021
Q3 | – | Sell |
-47,520
| Closed | -$192K | – | 9051 |
|
|
2021
Q2 | $207K | Buy |
47,520
+5,233
| +12% | +$21.3K | ﹤0.01% | 5219 |
|
|
2021
Q1 | $174K | Buy |
42,287
+6,130
| +17% | +$26.6K | ﹤0.01% | 5167 |
|
|
2020
Q4 | $144K | Buy |
36,157
+23,144
| +178% | +$74.9K | ﹤0.01% | 4307 |
|
|
2020
Q3 | $35K | Buy |
13,013
+947
| +8% | +$2.62K | ﹤0.01% | 4863 |
|
|
2020
Q2 | $33K | Sell |
12,066
-24,942
| -67% | -$69.6K | ﹤0.01% | 4598 |
|
|
2020
Q1 | $87K | Buy |
37,008
+11,520
| +45% | +$39.2K | ﹤0.01% | 3400 |
|
|
2019
Q4 | $120K | Sell |
25,488
-2,850
| -10% | -$11.7K | ﹤0.01% | 3524 |
|
|
2019
Q3 | $95K | Sell |
28,338
-2,063
| -7% | -$6.79K | ﹤0.01% | 3605 |
|
|
2019
Q2 | $100K | Sell |
30,401
-37,682
| -55% | -$109K | ﹤0.01% | 3351 |
|
|
2019
Q1 | $206K | Buy |
68,083
+33,037
| +94% | +$107K | ﹤0.01% | 2683 |
|
|
2018
Q4 | $95K | Sell |
35,046
-14,214
| -29% | -$46.8K | ﹤0.01% | 3196 |
|
|
2018
Q3 | $166K | Buy |
49,260
+47,511
| +2,716% | +$147K | ﹤0.01% | 3145 |
|
|
2018
Q2 | $5K | Sell |
1,749
-8,935
| -84% | -$22.2K | ﹤0.01% | 4823 |
|
|
2018
Q1 | $24K | Sell |
10,684
-4,573
| -30% | -$10.3K | ﹤0.01% | 4017 |
|
|
2017
Q4 | $30K | Buy |
15,257
+14,757
| +2,951% | +$32.1K | ﹤0.01% | 3994 |
|
|
2017
Q3 | $2K | Sell |
500
-1,300
| -72% | -$4.01K | ﹤0.01% | 4666 |
|
|
2017
Q2 | $6K | Buy |
+1,800
| New | +$5.1K | ﹤0.01% | 4390 |
|
|
2017
Q1 | – | Sell |
-300
| Closed | -$722 | – | 5153 |
|
|
2016
Q4 | $1K | Sell |
300
-5,155
| -95% | -$9.82K | ﹤0.01% | 4338 |
|
|
2016
Q3 | $9K | Hold |
5,455
| – | – | ﹤0.01% | 4086 |
|
|
2016
Q2 | $6K | Sell |
5,455
-2,000
| -27% | -$1.93K | ﹤0.01% | 4240 |
|
|
2016
Q1 | $6K | Buy |
7,455
+2,533
| +51% | +$2.45K | ﹤0.01% | 4176 |
|
|
2015
Q4 | $6K | Sell |
4,922
-104,200
| -95% | -$145K | ﹤0.01% | 4348 |
|
|
2015
Q3 | $186K | Sell |
109,122
-14,558
| -12% | -$28.5K | ﹤0.01% | 2557 |
|
|
2015
Q2 | $257K | Buy |
123,680
+70,637
| +133% | +$171K | ﹤0.01% | 2350 |
|
|
2015
Q1 | $144K | Buy |
53,043
+12,300
| +30% | +$31.2K | ﹤0.01% | 2636 |
|
|
2014
Q4 | $105K | Sell |
40,743
-5,654
| -12% | -$12.7K | ﹤0.01% | 2812 |
|
|
2014
Q3 | $85K | Buy |
46,397
+7,377
| +19% | +$16.1K | ﹤0.01% | 3145 |
|
|
2014
Q2 | $104K | Sell |
39,020
-65,253
| -63% | -$196K | ﹤0.01% | 2952 |
|
|
2014
Q1 | $365K | Sell |
104,273
-29,587
| -22% | -$131K | 0.01% | 1905 |
|
|
2013
Q4 | $600K | Buy |
133,860
+21,751
| +19% | +$88.6K | 0.01% | 1526 |
|
|
2013
Q3 | $455K | Buy |
112,109
+4,890
| +5% | +$21.4K | 0.01% | 1694 |
|
|
2013
Q2 | $446K | Buy |
+107,219
| New | +$414K | 0.01% | 1445 |
|
Other funds holding ATRS
Group One Trading's ATRS Position: Q2 2022 in Review
Group One Trading sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 13,427 shares — an estimated $55K sold.
Group One Trading first reported a position in ATRS in Q2 2013 and held it in 33 quarters. The position peaked at $600K in Q4 2013. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.
- Group One Trading reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
- Group One Trading sold 13,427 Antares Pharma, Inc. shares in Q2 2022, an estimated $55K.
- Group One Trading first reported a position in Antares Pharma, Inc. in Q2 2013 and held it in 33 quarters.
- Group One Trading's Antares Pharma, Inc. position peaked at $600K in Q4 2013.
- 1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.
Based on Group One Trading's 13F filing for Q2 2022, filed 11 Aug 2022.